USPTO serial 79308302
ABCAM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 26, 2022
- Examiner
- BLACK, MILDRED ELIZABETH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ABCAM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher M. Kindel
Christopher M. Kindel Pirkey Barber PLLC1801 East 6th Street, Suite 300Austin, TX 78702UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical diagnostic preparations and materials in the nature of substances, reagents and assays; diagnostic kits for single- and multi-plexed detection, quantification or identification consisting primarily of biological molecules, proteins, nucleic acids and small molecules for medical or clinical use, namely, for use in disease testing; diagnostic kits consisting primarily of reagents, particles, vials and buffers for medical or clinical use, namely, for use in disease testing; medical diagnostic assays for monitoring, identifying, detecting, or quantifying biological molecules or small molecules for medical or clinical use, namely, for use in disease testing; diagnostic kits consisting primarily of reagents, particles, vials and buffers for monitoring, identifying, detecting, or quantifying biological molecules or small molecules for medical or clinical use, namely, for use in disease testing; medical diagnostic single- and multi-plexed assays for analysis of proteins, nucleic acids and small molecules for medical or clinical use, namely, for use in disease testing | ACTIVE | — |
| 009 | Downloadable computer software for operating scientific and laboratory apparatus and instruments; downloadable computer software for detecting, identifying, reading, quantifying, decoding, tracking or analyzing nucleic acids, proteins, cells, molecules or encoded particles, and for processing, managing, tracking displaying, and creating reports of generated data; downloadable computer software for scientific, laboratory, clinical or medical analysis of cells, molecules or encoded particles; none of the aforesaid including microscope adapters | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Abcam plc
- Other trademarks owned by Abcam plc
- Other trademarks owned by Abcam plc
- Other trademarks owned by Abcam Limited
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named ABCAM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 20, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 26, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 1, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 1, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 26, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 26, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 6, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 19, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 19, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 19, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 5, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 4, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 10, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 10, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 10, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 10, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 21, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 22, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 22, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 16, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 16, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 15, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 10, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 8, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |